News summary

[Morning Announcementbluemarlin: Newtiger implements its first share repurchase; Shuanggun Technology extends the repurchase implementation period] Securities Times e Company Newsbluemarlin① Newtiger: On May 21, the company purchased back the company's shares through a centralized bidding transaction for the first time through a special securities account for share repurchase. 15bluemarlin.760,000 shares, accounting for the company's sharebluemarlin...

Newsletter text

[Morning announcement: Newtiger implemented the first share repurchase; Shuanggun Technology extended the repurchase implementation period] Securities Times e Company News, ① Newtiger: On May 21, the company used a special securities account for share repurchase for the first time to use centralized bidding transactions to repurchase 157,600 shares of the company's shares, accounting for 0.14% of the company's current total share capital, with a transaction amount of 3.5398 million yuan (excluding transaction costs).② Chunxing Jinggong: Recently, it was learned that the judicial freeze has been lifted for the remaining 15.535 million shares frozen by the Beijing City Second Intermediate Court due to a contract dispute between Sun Jiexiao, the company's controlling shareholder, and Weihong Fund Management (Beijing) Co., Ltd.③ Double Gun Technology: The board of directors agreed to extend the repurchase implementation period by 6 months, from May 21 to November 21.④ Huaren Pharmaceutical: Salbutamol Sulfate Injection of Anhui Hengxing Pharmaceutical, a wholly-owned subsidiary, has obtained the drug registration certificate and is deemed to have passed the consistency evaluation. Salbutamol sulfate injection is suitable for the treatment of respiratory diseases accompanied by bronchospasm such as bronchial asthma or wheezing bronchitis, and is a Class B product under national medical insurance.